Relevance of anti‐thyroperoxidase antibodies in immune thrombocytopenia in adults: A single‐centre cohort study
Nicolas Duhamel, Marie Ottavi, Sarah Lechtman, Nihal Martis, Charlotte Hinault‐Boyer, Julie Merindol, Pierre‐Yves Jeandel, Michael Levraut · 2026
Read Relevance of anti‐thyroperoxidase antibodies in immune thrombocytopenia in adults: A single‐centre cohort study by Nicolas Duhamel, Marie Ottavi, Sarah Lechtman, Nihal Martis, Charlotte Hinault‐Boyer, Julie Merindol, Pierre‐Yves Jeandel, Michael Levraut (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13674117.txt.
Description
A peer-reviewed research article from Europe PMC (2026). lished, biomarkers to predict first‐line treatment response, relapse and long‐term outcomes are lacking. Screening for anti‐nuclear (ANA), anti‐phospholipid (APL) or anti‐thyroid autoantibodies (ATA) is suggested during the diagnostic process. 1 , 2 ANA are detected in up to 20%–50% of patients with primary ITP 3 , 4 and may indicate a higher risk for chronic disease and overexposure to second‐line therapies. ATA, particularly anti‐thyroperoxidase (anti‐TPO) antibodies, are found in 10%–30% of ITP patients.
Catalog record
| CREATOR | Nicolas Duhamel, Marie Ottavi, Sarah Lechtman, Nihal Martis, Charlotte Hinault‐Boyer, Julie Merindol, Pierre‐Yves Jeandel, Michael Levraut |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |